two sulfur atoms

Industry

CPC
C07D473/20

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D473/00Heterocyclic compounds containing purine ring systems

Current Industry

C07D473/20two sulfur atoms

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Thioxanthine derivatives and their use as inhibitors of MPO
- Patent number 8,026,244
- Issue date Sep 27, 2011
- Astrazeneca AB
- Anna-Karin Tiden
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for preparing 1,3-dioxolane nucleosides
- Patent number 6,855,821
- Issue date Feb 15, 2005
- Pharmasset, Ltd.
- Jinfa Du
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase iv inhibition activity
- Patent number 6,413,975
- Issue date Jul 2, 2002
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase IV inhibition activity
- Patent number 6,319,928
- Issue date Nov 20, 2001
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase IV inhibition activity
- Patent number 6,294,541
- Issue date Sep 25, 2001
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 6,268,373
- Issue date Jul 31, 2001
- Euro-Celtique S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 6,025,361
- Issue date Feb 15, 2000
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 5,977,119
- Issue date Nov 2, 1999
- Euro-Celtique, S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds having PDE-IV inhibition activity
- Patent number 5,939,422
- Issue date Aug 17, 1999
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acetal-and ketal-substituted pyrimidine compounds
- Patent number 5,777,115
- Issue date Jul 7, 1998
- Cell Therapeutics, Inc.
- Alistair Leigh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds, their production and use
- Patent number 5,753,664
- Issue date May 19, 1998
- Takeda Chemical Industries, Ltd.
- Tetsuya Aono
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine compounds
- Patent number 5,525,607
- Issue date Jun 11, 1996
- Kyowa Hakko Kogyo Co., Ltd.
- Fumio Suzuki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfur-containing xanthine derivatives as adenosine antagonists
- Patent number 5,453,426
- Issue date Sep 26, 1995
- The United States of America as represented by the Department of Health and H...
- Kenneth A. Jacobson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acetal or ketal substituted xanthine compounds
- Patent number 5,440,041
- Issue date Aug 8, 1995
- Cell Therapeutics, Inc.
- Alistair Leigh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine derivatives
- Patent number 5,290,782
- Issue date Mar 1, 1994
- Kyowa Hakko Kogyo Co., Ltd.
- Fumio Suzuki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine Derivatives
- Patent number 4,981,857
- Issue date Jan 1, 1991
- Burroughs Wellcome Co.
- Susan M. Daluge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine derivatives
- Patent number 4,879,296
- Issue date Nov 7, 1989
- Burroughs Wellcome Co.
- Susan M. Daluge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Xanthine derivatives and their use in pharmaceutical compositions
- Patent number 4,454,138
- Issue date Jun 12, 1984
- Wuelfing; Johann A.
- Joachim E. Goring
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3135753
- Patent number 3,135,753
- Issue date Jun 2, 1964
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2697709
- Patent number 2,697,709
- Issue date Dec 21, 1954
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Thioxanthine Derivatives and Their Use as Inhibitors of MPO
- Publication number 20090286813
- Publication date Nov 19, 2009
- AstraZeneca AB
- Donald Pivonka
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thioxanthine Derivatives and Their Use as Inhibitors of MPO
- Publication number 20090149475
- Publication date Jun 11, 2009
- AstraZeneca AB
- Anna-Karin Tiden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Processes for preparing 1,3-dioxolane nucleosides
- Publication number 20040087806
- Publication date May 6, 2004
- Jinfa Du
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purine compounds having PDE IV inhibitory activity and methods of s...
- Publication number 20030073834
- Publication date Apr 17, 2003
- David J. Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

two sulfur atoms

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Thioxanthine derivatives and their use as inhibitors of MPO

Processes for preparing 1,3-dioxolane nucleosides

Purine derivatives having phosphodiesterase iv inhibition activity

Purine derivatives having phosphodiesterase IV inhibition activity

Purine derivatives having phosphodiesterase IV inhibition activity

Trisubstituted thioxanthines

Trisubstituted thioxanthines

Trisubstituted thioxanthines

Chemical compounds having PDE-IV inhibition activity

Acetal-and ketal-substituted pyrimidine compounds

Heterocyclic compounds, their production and use

Xanthine compounds

Sulfur-containing xanthine derivatives as adenosine antagonists

Acetal or ketal substituted xanthine compounds

Xanthine derivatives

Purine Derivatives

Xanthine derivatives

Xanthine derivatives and their use in pharmaceutical compositions

3135753

2697709

Patents Applicationslast 30 patents

Thioxanthine Derivatives and Their Use as Inhibitors of MPO

Thioxanthine Derivatives and Their Use as Inhibitors of MPO

Processes for preparing 1,3-dioxolane nucleosides

Purine compounds having PDE IV inhibitory activity and methods of s...